Edouard Guillet
Board Observer representing IPF Partners
Spin Guard
Spin Master
Australia
Biography
Edouard Guillet is a co-founder and managing director of IPF Partners, a leading alternative financing provider focused on the European healthcare sector. Edouard has over 17 years of experience in the healthcare industry. He previously led the Hepatitis and Anti-Fungal Business Unit of Gilead Sciences in France, the leading virology biotech company, after being Gilead Sciences’ Marketing Director, a senior Marketing Executive at Medtronic, the global leader in medical technologies and a Principal at the Boston Consulting Group, a leading strategic consultancy. Edouard Guillet started his career in investment banking with CCF (now HSBC). He holds an MsC from HEC in Paris. IPF Partners manages investments funds that invest directly in emerging, commercial-stage European pharma/biotech, medtech, diagnostics and e-health companies. IPF provides customised, low- to non-dilutive debt financing to market leading healthcare companies. Typical investments ranges from €5-30m over 3-7 years duration.
Research Interest
Molecular Biology and Molecular Genetics
